Markets › United States › NAS › VRAX

Virax Biolabs Group Ltd

NAS:VRAXHealthcarenasdaq_composite

$1.24+0.40%LiveIn session · ≈ AED 4.55 · Market cap $1.67M · Next earnings Wed 2 Dec

USD millions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Net income	(0.7)	(1.7)	(5.5)	(6.7)	(6.1)	(5.0)	+17.2%
Depreciation & amortization	0.0	0.0	0.0	0.1	0.3	0.4	+27.8%
Stock-based compensation	0.0	0.3	1.7	1.0	0.4	0.1	−64.3%
Change in working capital	0.1	0.6	(0.2)	(1.1)	0.6	0.3	−56.7%
Operating cash flow	(0.6)	(0.8)	(4.2)	(6.2)	(4.6)	(4.6)	−1.3%
Capital expenditure	0.0	0.0	(0.2)	(1.2)	(0.6)	(0.3)	+57.6%
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	—
Investing cash flow	0.0	0.0	(0.2)	(1.2)	(0.6)	(0.3)	+57.6%
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	0.0	0.1	0.1	(0.2)	(0.1)	(0.1)	−1.6%
Financing cash flow	0.6	0.8	13.7	1.6	5.8	7.1	+22.1%
Free cash flow	(0.6)	(0.8)	(4.4)	(7.4)	(5.2)	(4.9)	+5.6%
Net change in cash	(0.0)	0.0	9.3	(5.8)	0.6	2.2	+245.5%